Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
64 Cards in this Set
- Front
- Back
Why doesn't the adaptive immune system normally attack your own body tissues?
|
It has created safe guards to make sure that antibodies aren't made that will attack self cells, etc.
|
|
Differentiate innate from adaptive immunity
|
innate is very general, adaptive is incredibly specific
|
|
differentiate humoral from cellular immunity
|
humoral involves antibodies and cellular involves T-cells
|
|
where do matured B and T cells migrate to?
|
Lymphoid tissue such as spleen, but especially lymph nodes
|
|
Humoral immunity involves what cells? What provides humoral immunity?
|
B cells; antibodies
|
|
Cellular immunity involves what cells?
|
T cells
|
|
Antigen:
|
a substance that causes the body to produce specific antibodies or sensitized T cells
|
|
epitope/antigenic deteriminant sites
|
Ab interact w/these; can be parts of proteins, RNA, DNA, or other macromolecules; the structural feature recognized by the antibody!
|
|
immunoglobulins (Ig) |
antibodies; globular proteins |
|
what determines valence for Ab?
|
the number of epitopes
|
|
V=?
|
the variable part of the aby
|
|
C=?
|
the constant part of the aby
|
|
Characteristics of IgG Antibodies:
|
-Monomer
-80% of serum Abs -Fix Complement -In blood, lymph and intestine -cross placenta -enhance phagocytosis: neutralize toxins and viruses; protects fetus and newborn -half-life = 23 days! -valence = 2 |
|
Characteristics of IgM antibodies:
|
-Pentamer
-5-10% of serum Abs -Fix complement -In blood, lymph, and on B cells -Agglutinate microbes; first Ab produced in response to infection -half-life = 5 days -valence = 10 |
|
Characteristics of IgA antibodies:
|
-Dimer
-10-15% of serum Abs -In secretions -Mucosal protection -half-life = 6 days -valence = 4 |
|
Characteristics of IgD antibodies
|
-monomer
-0.2% of serum Abs -In blood, in lymph, and on B cells -On B cells, initiates immune response -half-life = 3 days - valence = 2 |
|
Characteristics of IgE antibodies:
|
-monomer
-0.002% of serum Abs -On mast cells, basophils and in blood -Allergic rxns; lysis of parasitic worms -half-life = 2 days -valence = 2 |
|
serology
|
the study of rxns b/n antibodies & antigens
|
|
antiserum
|
the generic term for serum b/c it contains Ab (part of serum)
|
|
Globulins
|
serum proteins
|
|
immunoglobulins
|
Antibodies (proteins)
|
|
Gamma globulin
|
serum fraction containing Ab (part of antiserum)
|
|
Major Histocompatibility Complex (MHC)
|
expressed on mammalian cells; keeps us from damaging our own cells
|
|
T-dependent antigens
|
-Ag presented w/self MHC to T helper cell
-T helper cell produces cytokines that activate the B cell to produce antibodie -Reads degraded products from microorganisms being spit out by macrophages |
|
T-independent antigens
|
-stimulate B cell to make Abs immediately
-reads epitopes |
|
Clonal Selection
|
-The selection of Abs that can interact with a specific antigen to produce more antibodies
|
|
plasma cells
|
B cells that make antibodies
|
|
memory cells
|
B cells that live forever (could) and cause secondary immune response
|
|
clonal deletion
|
eliminates harmful B cells
|
|
What are the 5 results of Ag-Ab binding?
|
1. Agglutination
2. Opsonization 3. Complement Fixation 4. Antibody-Dependent Cell-Mediated Cytoxicity 5. Neutralization |
|
Agglutination
|
-reduces #s of infectious units to be dealt with
|
|
opsonization
|
-coating antigen w/antibody enhances phagocytosis
|
|
Complement Fixation
|
-causes inflammation and cell lysis
|
|
Antibody-dependent cell-mediated cytoxicity
|
-Antibodies attached to target cell cause destruction by macrophages, eoinophis (secrete perforin and lytic enzymes) and NK cells
|
|
Neutralization
|
-blocks adhesion of bacteria & viruses to mucosa
-Blocks attachment of toxins to mucosa |
|
T-cell receptors (TCRs)
|
how t cells respond to Ag
|
|
antigen-presenting cells (APCs)
|
required by t cells to recognize antigens
|
|
what 2 things can pathogens entering GI or respiratory tracts pass thru?
|
M (microfold) cells or Peyer's patches
|
|
T helper 1 cells make? what do those products do?
|
IFN-gamma, activating cells related to cell-mediated immunity, macrophages, and Abs (useful against viruses and other intracellular pathogens)
|
|
T helper 2 cells activate what to produce what?
|
activate eosinophils and B cells to produce IgE
|
|
T Cytotoxic Cells (CD8+/ Tc cells)
|
target cells that are self-carrying endogenous antigens (e.g., virus-infected cells)
|
|
what are Tc cell activated into? What do they then perform?
|
Cytotoxic T lymphocytes; CTLs; recognize Ag + MHC I; induce apoptosis in target cell
|
|
what do CTLs release?
|
perforin and granzymes
|
|
antigen-presenting cells
|
digest antigen by digesting a microbe & present parts of this microbe on their surface
|
|
what are the 3 Ag fragments on APC surface w/MHC?
|
1. B cells
2. Dendritic cells 3. Activated macrophages |
|
Natural Killer Cells
|
granular leukocytes that destroy cells that don't express MHC I
-kill virus-infected and tumor cells -attack parasites |
|
What does over-production lead to?
|
cytokine storm
|
|
IL-1
|
stimulates T helper cells in presence of antigens; attracts phagocytes
|
|
IL-2
|
proliferation of antigen-stimulated CD4+ T helper cells, proliferation and differentiation of B cells ;activation of CD8+ T cells and NK cells
|
|
IL-4 & IL-5
|
activate eosinophils, good against parasites (but also cause allergies)
|
|
chemokines
|
induce the migration of leukocytes
|
|
TNF-alpha
|
-by T helper 1 cells
-promotes inflammation |
|
hematopoietic cytokines
|
influence differentiation of blood stem cells
|
|
IFN-alpha and IFN-beta
|
response to viral infection; interfere w/protein synthesis
|
|
IFN-gamma
|
by T helper 1 cells
-stimulates macrophage activity (good for cells that have been invaded by e.g., Salmonella, Shigella) |
|
antibody titer
|
the amt. of Ab in serum
|
|
Primary response
|
occurs after initial contact w/Ag
|
|
Secondary (memory) response
|
occurs after 2nd exposure
|
|
passive immunity
|
immediate (Abs present) but doesn't last
|
|
Active immunity
|
takes time to develop but lasts longer
|
|
Naturally acquired active immunity
|
resulting from infection
|
|
naturally acquired passive immunity
|
transplacental or via colostrum (breastmilk)
|
|
artificially acquired active immunity
|
injection of Ag (vaccination)
|
|
artificially acquired passive immunity
|
injection of Ab (e.g., used to neutralize snake venoms)
|